Edition:
United States

Viking Therapeutics Inc (VKTX.OQ)

VKTX.OQ on NASDAQ Stock Exchange Capital Market

8.22USD
3:59pm EST
Change (% chg)

$-0.38 (-4.42%)
Prev Close
$8.60
Open
$8.56
Day's High
$8.65
Day's Low
$8.05
Volume
788,549
Avg. Vol
892,009
52-wk High
$24.00
52-wk Low
$3.70

Latest Key Developments (Source: Significant Developments)

Viking Therapeutics Announces Pricing Of $175.8 Million Public Offering Of Common Stock
Thursday, 20 Sep 2018 08:06pm EDT 

Sept 20 (Reuters) - Viking Therapeutics Inc ::VIKING THERAPEUTICS ANNOUNCES PRICING OF $175.8 MILLION PUBLIC OFFERING OF COMMON STOCK.SAYS PUBLIC OFFERING OF 9.50 MILLION COMMON SHARES PRICED AT $18.50PER SHARE.  Full Article

Viking Therapeutics Announces Proposed Public Offering Of Common Stock
Wednesday, 6 Jun 2018 04:01pm EDT 

June 6 (Reuters) - Viking Therapeutics Inc ::VIKING THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.VIKING THERAPEUTICS INC - INTENDS TO USE NET PROCEEDS FROM OFFERING FOR CONTINUED DEVELOPMENT OF ITS VK5211, VK2809 AND VK0214 PROGRAMS.  Full Article

Viking Therapeutics says Resale By Selling Stockholders Of Up To 2.6 Mln Shares
Wednesday, 20 Dec 2017 05:35pm EST 

Dec 20 (Reuters) - Viking Therapeutics Inc ::VIKING THERAPEUTICS - RESALE BY SELLING STOCKHOLDERS OF UP TO 2.6 MILLION SHARES OF CO'S COMMON STOCK - SEC FILING.  Full Article

Sphera Funds Management Ltd Reports 7.43 Pct Passive Stake In Viking Therapeutics
Monday, 18 Dec 2017 09:59am EST 

Dec 18 (Reuters) - Viking Therapeutics Inc ::SPHERA FUNDS MANAGEMENT LTD REPORTS 7.43 PERCENT PASSIVE STAKE IN VIKING THERAPEUTICS INC AS OF DECEMBER 7 - SEC FILING.  Full Article

Viking Therapeutics Announces Closing Of Public Offering
Monday, 11 Dec 2017 04:15pm EST 

Dec 11 (Reuters) - Viking Therapeutics Inc ::VIKING THERAPEUTICS ANNOUNCES CLOSING OF PUBLIC OFFERING OF COMMON STOCK.  Full Article

Viking Therapeutics Announces Pricing Of $12.8 Million Public Offering Of Common Stock
Wednesday, 6 Dec 2017 08:09pm EST 

Dec 6 (Reuters) - Viking Therapeutics Inc ::VIKING THERAPEUTICS ANNOUNCES PRICING OF $12.8 MILLION PUBLIC OFFERING OF COMMON STOCK.VIKING THERAPEUTICS INC- ‍ANNOUNCED PRICING OF ITS PUBLIC OFFERING OF 5,130,435 SHARES OF ITS COMMON STOCK AT A PRICE TO PUBLIC OF $2.50 PER SHARE​.  Full Article

Viking Therapeutics Announces Proposed Public Offering Of Common Stock
Tuesday, 5 Dec 2017 04:18pm EST 

Dec 5 (Reuters) - Viking Therapeutics Inc ::VIKING THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.VIKING THERAPEUTICS - INTENDS TO USE NET PROCEEDS FROM STOCK OFFERING FOR CONTINUED DEVELOPMENT OF ITS VK5211, VK2809 AND VK0214 PROGRAMS.  Full Article

Viking Therapeutics reports third quarter 2017 financial results
Wednesday, 8 Nov 2017 04:05pm EST 

Nov 8 (Reuters) - Viking Therapeutics Inc :Viking Therapeutics reports third quarter 2017 financial results and provides corporate update.Q3 loss per share $0.22.Q3 earnings per share view $-0.20 -- Thomson Reuters I/B/E/S.  Full Article

Viking Therapeutics files for sale of up to 6.9 mln shares by selling stockholder
Tuesday, 17 Oct 2017 05:09pm EDT 

Oct 17 (Reuters) - Viking Therapeutics Inc :Viking Therapeutics Inc files for sale of up to 6.9 million shares of co's common stock by selling stockholder Lincoln Park Capital Fund Llc‍‍​ - SEC filing.  Full Article

Viking shares surge after fatty liver drug trial

Viking Therapeutics Inc's shares more than doubled in value on Tuesday after promising data from a mid-stage trial of its fatty liver drug were seen as topping that from larger rival Madrigal Pharmaceuticals .